ACRUX (ASX: ACR) IS AN AUSTRALIAN DRUG DELIVERY COMPANY, DEVELOPING AND COMMERCIALISING A RANGE OF PATIENT-PREFERRED PHARMACEUTICAL PRODUCTS FOR GLOBAL MARKETS. USING INNOVATIVE TECHNOLOGY, OUR DRUGS CAN BE ADMINISTERED THROUGH THE SKIN OR NAILS, BOTH TOPICALLY AND TRANSDERMALLY.
Acrux has three products marketed by licensees within major markets around the world, as well as additional products at earlier stages of development. Our unique technology, used in marketed products such as Axiron®, Evamist® and Lenzetto®, are based on fast-drying, low volume, accurately-dosed solutions containing penetration enhancers, that when applied topically, deposit the drugs through the skin with long-lasting effects. We are currently developing a range of generic and patent-preferred products. Acrux has on-site laboratories, a Good Manufacturing Practice (GMP) manufacturing suite, clinical and the commercial experience to facilitate these development projects.
Acrux is building a diversified portfolio, maximising its existing assets and developing both proprietary and generic projects for longer term growth. Each growth wave provides a different investment profile, formulation development cycle and clinical and regulatory program. Acrux will continue to commercialise its products with corporate partners. The timing of partnerships will be assessed to accommodate investment requirements and capital returns to shareholders.
Acrux has three products marketed by licensees within major markets around the world, as well as additional products at earlier stages of development. Our unique technology, used in marketed products such as Axiron®, Evamist® and Lenzetto®, are based on fast-drying, low volume, accurately-dosed solutions containing penetration enhancers, that when applied topically, deposit the drugs through the skin with long-lasting effects. We are currently developing a range of generic and patent-preferred products. Acrux has on-site laboratories, a Good Manufacturing Practice (GMP) manufacturing suite, clinical and the commercial experience to facilitate these development projects.